Fatty Liver Disease Research Study Self-Scheduler

Basic Criteria:

• Be 18 years or older
• Be diagnosed with or have suspected Fatty Liver Disease
• Have a BMI 25 or more (Click the link to calculate)
• Not have Type 1 Diabetes
• Not have been on a GLP-1 in the past 3 months

Answers Must Be Yes: 

1. Are you 18 years of age or older?

2. Have you been diagnosed with or suspected to have Fatty Liver Disease? 

3. If you have type 2 diabetes, have you been on a stable dose of insulin or oral medication for at least 3 months?

4. If you take an SGLT2 inhibitor (for example, dapagliflozin), have you been on a stable dose for at least 6 months?

Answers Must Be No: 

1. Have you ever had liver decompensation, such as variceal bleeding, ascites, or hepatic encephalopathy?

2. Have you ever been diagnosed with cirrhosis from a liver biopsy?

3. Have you been told you have any other chronic liver disease, such as:

   • Alcohol-related liver disease

   • Hepatitis B (positive surface antigen)

   • Active Hepatitis C (positive RNA test in the past 2 years)

   • Primary biliary cholangitis

   • Primary sclerosing cholangitis

   • Autoimmune liver disease

   • Hemochromatosis

   • Wilson’s disease

   • Alpha-1 antitrypsin deficiency

   • Drug-induced liver injury

   • Any other liver disease besides MASLD (Metabolic dysfunction-associated steatotic liver disease)

4. Is your BMI below 25 kg/m²?

5. Have you lost more than 5 kg (11 lbs) in the past 3 months?

6. Have you had weight loss surgery (such as gastric bypass or sleeve gastrectomy) in the past year or have one planned?

7. Have you had liposuction, cryolipolysis, or abdominoplasty within the past year?

8. Have you had or planned any endoscopic or device-based obesity treatments, such as an intragastric balloon or gastric band, within the past 6 months?

9. Is your obesity caused by a hormonal disorder (such as Cushing’s syndrome) or a genetic/syndromic condition (such as Prader-Willi or MC4R deficiency)?

10. Is your HbA1c higher than 10%?

11. Have you recently changed your diabetes medications within the last 3 months?

12. Are you using bolus (short-acting) insulin?

13. Do you have type 1 diabetes or any other type of diabetes besides type 2?

14. Have you had diabetic ketoacidosis, hyperosmolar coma, or severe hypoglycemia in the past 3 months?

15. Have you had a heart attack, stroke, heart surgery, or hospitalization for heart failure in the past 3 months?

16. Do you have severe (Class IV) heart failure?

17. Do you or a first-degree relative have a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2)?

18. Have you taken any of the following within the last 6 months:

• GLP-1 receptor agonists

• GIP/GLP-1 receptor agonists

• GLP-1/Glucagon receptor agonists

• GIP/GLP-1/Glucagon receptor agonists

21. Have you taken Pramlintide or Amylin receptor agonists within the last 3 months?

22. Have you used any prescription or over-the-counter weight loss drugs in the last 3 months, such as:

• Orlistat

• Sibutramine

• Phenylpropanolamine

• Mazindol

• Phentermine or Phentermine/Topiramate

• Naltrexone/Bupropion

Please note that additional study criteria will apply.

Please confirm your eligibility before your appointment by calling 248-864-5242.

If you do not see an available appointment, please call 248-864-5242 for availability.

Transportation may be available. Call 248-864-5242.